GENTILI, Federica
 Distribuzione geografica
Continente #
NA - Nord America 1.510
EU - Europa 384
AS - Asia 105
AF - Africa 39
SA - Sud America 3
Totale 2.041
Nazione #
US - Stati Uniti d'America 1.483
SE - Svezia 104
IT - Italia 83
DE - Germania 70
IN - India 59
FI - Finlandia 49
CN - Cina 44
BJ - Benin 33
UA - Ucraina 21
AT - Austria 17
BG - Bulgaria 14
CA - Canada 14
GB - Regno Unito 13
BZ - Belize 9
BE - Belgio 5
TG - Togo 5
MX - Messico 4
AR - Argentina 3
IE - Irlanda 3
RO - Romania 3
KR - Corea 1
NL - Olanda 1
PL - Polonia 1
SG - Singapore 1
ZA - Sudafrica 1
Totale 2.041
Città #
Fairfield 250
Ashburn 159
Woodbridge 118
Chandler 98
Seattle 92
Cambridge 80
Wilmington 62
Ann Arbor 58
Houston 58
Dearborn 54
Princeton 46
San Jose 40
Fasano 33
Frankfurt am Main 33
Plano 33
San Paolo di Civitate 32
Bremen 27
Beijing 19
Lawrence 17
Millbury 17
Washington 17
Boston 16
Helsinki 16
San Mateo 16
Vienna 16
Dallas 15
San Diego 14
Sofia 14
Rome 13
Ottawa 11
Fremont 10
Jacksonville 10
Saint Louis 10
Belize City 9
Auburn Hills 8
Boardman 7
Hefei 7
Norwalk 7
Chicago 6
Des Moines 6
Brussels 5
Lomé 5
Andover 4
Columbus 4
Falls Church 4
Grafing 4
Dublin 3
Federal 3
Toronto 3
Atlanta 2
Indiana 2
Los Angeles 2
Mexico City 2
Nanchang 2
Ningbo 2
Prescot 2
Taizhou 2
Torre del Greco 2
Zhengzhou 2
Augusta 1
Baotou 1
Berlin 1
Changsha 1
Chaoyang 1
Chengdu 1
Fuzhou 1
Guangzhou 1
Jinan 1
Kenmore 1
Lanzhou 1
Leawood 1
London 1
Muizenberg 1
Nanjing 1
Provo 1
Redwood City 1
Sacramento 1
Sesto Fiorentino 1
Southend 1
Xian 1
Totale 1.630
Nome #
Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation 99
CHRONIC RENAL DYSFUNCTION AFTER LIVER TRANSPLANTATION: RISK FACTORS AND A NEW PREDICTIVE SCORE 91
Chronic renal dysfunction after liver transplantation: Incidence and risk factors 87
Does nutritional status influence the outcome in patients undergoing liver transplantation in the “MELD” era? 85
Predictive Factors of Recurrence of Hepatocellular Carcinoma After Liver Transplantation: A Multivariate Analysis 79
CHRONIC RENAL DYSFUNCTION AFTER LIVER TRANSPLANTATION: RISK FACTORS AND A NEW PREDICTIVE SCORE 79
One month post-operative serum insulin predicts serum aminotransferase elevation and fibrosis progression due to HCV recurrence after liver transplantation 76
COMBINED THERAPY WITH LOW DOSE HEPATITIS B IMMUNOGLOBULIN (HBIG) AND LAMIVUDINE (LAM) IN PATIENTS TRANSPLANTED FOR HBV CHRONIC LIVER DISEASE: LONG TERM EFFICACY AND COSTS 76
EFFECT OF RIBAVIRIN PRE-TREATMENT ON EARLY VIROLOGICAL RESPONSE OF RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION 76
Improvement of nutritional status in malnourished cirrhotic patients one year after liver transplantation 74
PREDICTIVE RISK FACTORS OF RECURRENCE OF HEPATOCELLULAR CARCINOMA AFTER LIVER TRANSPLANTATION 73
Nutritional status: its influence on the outcome of patients undergoing liver transplantation 72
THE PREDICTION OF CHRONIC RENAL DYSFUNCTION FOLLOWING LIVER TRANSPLANTATION: A TIME-DEPENDENT ANALYSIS 71
Hepatic steatosis after liver transplantation: Prevalence and associated factors 69
ONE MONTH POST-OPERATIVE SERUM INSULIN PREDICTS SERUM AMINOTRANSFERASE ELEVATION AND FIBROSIS PROGRESSION DUE TO HCV RECURRENCE AFTER LIVER TRANSPLANTATION 68
Predictors of outcome of liver transplantation in patients with liver cirrhosis and hepatocellular carcinoma 68
VALIDATION OF A PREDICTIVE MODEL FOR CHRONIC RENAL DYSFUNCTION FOLLOWING LIVER TRANSPLANTATION 68
Immune-mediated liver dysfunction after antiviral treatment in liver transplanted patients with hepatitis c: Allo or autoimmune de novo hepatitis? 65
Short-term changes in nutritional status, energy expenditure, dietary intake in patients undergoing liver transplantation 64
Predictive Factors of Outcome After Liver Transplantation in Patients With Cirrhosis and Hepatocellular Carcinoma 63
Ribavirin priming improves the virological response to antiviral treatment in transplanted patients with recurrent hepatitis C: a pilot study 63
SHORT TERM EFFECTS OF CONVERSION FROM TWICE-DAILY TO ONCE-DAILY TACROLIMUS FORMULATION IN LIVER TRANSPLANT PATIENTS 57
Molecular mechanisms underlying muscle loss in cirrhotic patients 55
Predictive Factors of Outcome After Liver Transplantation in Patients With Cirrhosis and Hepatocellular Carcinoma 52
Estrado de nutrition, composicion corporal y metabolismo energetico en pacientes con cirrosis epatica 51
SEQUENTIAL CHANGES IN NUTRITIONAL STATUS, ENERGY EXPENDITURE, DIETARY INTAKE DURING THE FIRST SIX MONTHS AFTER LIVER TRANSPLANTATION 51
Actualidad en la pathogenesis y tratamiento de la encefalopatia epatica 48
AUTOIMMUNE DE NOVO HEPATITIS FOLLOWING ANTIVIRAL TREATMENT FOR HEPATITIS C RECURRENCE AFTER LIVER TRANSPLANTATION 48
AUTOIMMUNE DE NOVO HEPATITIS IN TRANSPLANTED PATIENTS FOLLOWING ANTIVIRAL TREATMENT FOR HEPATITIS C RECURRENCE 45
CALCINEURIN INHIBITORS REDUCTION IN LIVER TRANSPLANTED PATIENTS WITH CHRONIC RENAL DYSFUNCTION: RESULTS IN CURRENT CLINICAL PRACTICE 42
SUCCESSFUL COMBINED LONG TERM PROPHYLAXIS WITH LAMIVUDINE AND LOW DOSE HEPATITIS B IM IMMUNOGLOBULIN IN PATIENTS TRANSPLANTED FOR HBV CHRONIC LIVER DISEASE. 41
FACTORS INFLUENCING SUSTAINED VIROLOGICAL RESPONSE IN PATIENTS TREATED WITH PEGYLATED INTERFERON AND RIBAVIRIN FOR RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION 30
SUCCESSFUL COMBINED LONG TERM PROPHYLAXIS WITH LAMIVUDINE AND LOW DOSE HEPATITIS B IM IMMUNOGLOBULIN IN PATIENTS TRANSPLANTED FOR HBV CHRONIC LIVER DISEASE 29
Totale 2.115
Categoria #
all - tutte 4.599
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.599


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019237 0 0 0 0 0 0 0 0 2 45 109 81
2019/2020650 67 16 5 18 48 259 74 53 57 26 18 9
2020/2021136 17 21 7 12 1 4 2 13 13 8 2 36
2021/2022363 1 12 34 15 50 13 3 31 50 28 47 79
2022/2023441 67 83 38 96 42 35 14 12 38 7 7 2
2023/2024153 8 17 23 9 26 58 0 12 0 0 0 0
Totale 2.115